Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Advanced Colorectal Cancer With Liver Metastases or Lung Metastases That Are Potentially Removable by Surgery

NCT00513266 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

35

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Cancer
Metastatic Cancer

Interventions

BIOLOGICAL: bevacizumab
BIOLOGICAL: cetuximab
DRUG: fluorouracil
DRUG: irinotecan hydrochloride
DRUG: leucovorin calcium
DRUG: oxaliplatin
OTHER: laboratory biomarker analysis
PROCEDURE: adjuvant therapy
PROCEDURE: biopsy
PROCEDURE: conventional surgery
PROCEDURE: neoadjuvant therapy

Sponsor

Centre Hospitalier Universitaire Vaudois